{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:19:08Z","timestamp":1788135548081,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Yinchuan City Science and Technology Program Project","award":["2024RKX011"],"award-info":[{"award-number":["2024RKX011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-026-06531-8","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:57:17Z","timestamp":1781841437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ITGA7 interacts with FN1 to suppress the PI3K\/AKT signaling pathway and inhibit thyroid cancer progression"],"prefix":"10.1007","volume":"152","author":[{"given":"Hui","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QiLun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FaXuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"6531_CR1","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2147\/CMAR.S160379","volume":"10","author":"A Bhandari","year":"2018","unstructured":"Bhandari A, Xia E, Zhou Y, Guan Y, Xiang J, Kong L et al (2018) ITGA7 functions as a tumor suppressor and regulates migration and invasion in breast cancer. Cancer Manag Res 10:969\u2013976","journal-title":"Cancer Manag Res"},{"issue":"6","key":"6531_CR2","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1002\/jcb.26651","volume":"119","author":"X Cai","year":"2018","unstructured":"Cai X, Liu C, Zhang TN, Zhu YW, Dong X, Xue P (2018) Down-regulation of FN1 inhibits colorectal carcinogenesis by suppressing proliferation, migration, and invasion. J Cell Biochem 119(6):4717\u20134728","journal-title":"J Cell Biochem"},{"issue":"10","key":"6531_CR3","doi-asserted-by":"publisher","first-page":"e4242","DOI":"10.1210\/clinem\/dgab210","volume":"106","author":"CE Cherella","year":"2021","unstructured":"Cherella CE, Richman DM, Liu E, Frates MC, Modi BP, Zendejas B et al (2021) Predictors of bilateral disease in pediatric differentiated thyroid cancer. J Clin Endocrinol Metab 106(10):e4242\u2013e4250","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6531_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"J Cooper","year":"2019","unstructured":"Cooper J, Giancotti FG (2019) Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell 35(3):347\u2013367","journal-title":"Cancer Cell"},{"key":"6531_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110714","volume":"123","author":"RM Deng","year":"2023","unstructured":"Deng RM, Zhou J (2023) The role of PI3K\/AKT signaling pathway in myocardial ischemia-reperfusion injury. Int Immunopharmacol 123:110714","journal-title":"Int Immunopharmacol"},{"key":"6531_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.109465","volume":"66","author":"JC Ge","year":"2020","unstructured":"Ge JC, Wang YX, Chen ZB, Chen DF (2020) Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma. Cell Signal 66:109465","journal-title":"Cell Signal"},{"key":"6531_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.812278","volume":"8","author":"QS Geng","year":"2021","unstructured":"Geng QS, Huang T, Li LF, Shen ZB, Xue WH, Zhao J (2021) Over-expression and prognostic significance of FN1, correlating with immune infiltrates in thyroid cancer. Front Med 8:812278","journal-title":"Front Med"},{"issue":"2","key":"6531_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/abbs\/gmz144","volume":"52","author":"Y Guan","year":"2020","unstructured":"Guan Y, Bhandari A, Xia E, Kong L, Zhang X, Wang O (2020) Downregulating integrin subunit alpha 7 (ITGA7) promotes proliferation, invasion, and migration of papillary thyroid carcinoma cells through regulating epithelial-to-mesenchymal transition. Acta Biochim Biophys Sin 52(2):116\u2013124","journal-title":"Acta Biochim Biophys Sin"},{"issue":"1","key":"6531_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.stem.2017.04.009","volume":"21","author":"TL Haas","year":"2017","unstructured":"Haas TL, Sciuto MR, Brunetto L, Valvo C, Signore M, Fiori ME et al (2017) Integrin \u03b17 is a functional marker and potential therapeutic target in glioblastoma. Cell Stem Cell 21(1):35-50.e9","journal-title":"Cell Stem Cell"},{"issue":"21","key":"6531_CR10","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1080\/15384101.2022.2092817","volume":"21","author":"J Kang","year":"2022","unstructured":"Kang J, Wang Y, Guo X, He X, Liu W, Chen H et al (2022) N-acetylserotonin protects PC12 cells from hydrogen peroxide induced damage through ROS mediated PI3K \/ AKT pathway. Cell Cycle 21(21):2268\u20132282","journal-title":"Cell Cycle"},{"issue":"1","key":"6531_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/annonc\/mdr117","volume":"23","author":"E Kapiteijn","year":"2012","unstructured":"Kapiteijn E, Schneider TC, Morreau H, Gelderblom H, Nortier JWR, Smit JWA (2012) New treatment modalities in advanced thyroid cancer. Ann Oncol 23(1):10\u201318","journal-title":"Ann Oncol"},{"issue":"4","key":"6531_CR12","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.bpj.2019.07.002","volume":"117","author":"TM Kennelly","year":"2019","unstructured":"Kennelly TM, Li Y, Cao Y, Qwarnstrom EE, Geoghegan M (2019) Distinct binding interactions of \u03b1(5)\u03b2(1)-integrin and proteoglycans with fibronectin. Biophys J 117(4):688\u2013695","journal-title":"Biophys J"},{"issue":"2","key":"6531_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/path.4567","volume":"237","author":"V Laszlo","year":"2015","unstructured":"Laszlo V, Hoda MA, Garay T, Pirker C, Ghanim B, Klikovits T et al (2015) Epigenetic down-regulation of integrin \u03b17 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma. J Pathol 237(2):203\u2013214","journal-title":"J Pathol"},{"issue":"1","key":"6531_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12943-022-01600-1","volume":"21","author":"X Li","year":"2022","unstructured":"Li X, Wang J, Lin W, Yuan Q, Lu Y, Wang H et al (2022) circEXOC6B interacting with RRAGB, an mTORC1 activator, inhibits the progression of colorectal cancer by antagonizing the HIF1A-RRAGB-mTORC1 positive feedback loop. Mol Cancer 21(1):135","journal-title":"Mol Cancer"},{"issue":"2","key":"6531_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/path.5125","volume":"246","author":"X Li","year":"2018","unstructured":"Li X, Wang J, Zhang C, Lin C, Zhang J, Zhang W et al (2018) Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7. J Pathol 246(2):166\u2013179","journal-title":"J Pathol"},{"issue":"1","key":"6531_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3892\/ol.2022.13612","volume":"25","author":"M Liang","year":"2023","unstructured":"Liang M, Liu C, Lei T, Guo S, Min J (2023) Effect of integrin \u03b17 on cell proliferation, invasion, apoptosis and the PI3K\/AKT pathway, and its association with clinicopathological features in endometrial cancer. Oncol Lett 25(1):26","journal-title":"Oncol Lett"},{"issue":"1","key":"6531_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41598-024-83369-5","volume":"15","author":"M Liu","year":"2025","unstructured":"Liu M, Chen P, Wei B, Tan HL, Zhao YX, Ai L et al (2025) FN1 shapes the behavior of papillary thyroid carcinoma through alternative splicing of EDB region. Sci Rep 15(1):327","journal-title":"Sci Rep"},{"issue":"19","key":"6531_CR18","doi-asserted-by":"publisher","first-page":"8104","DOI":"10.1158\/0008-5472.CAN-08-2132","volume":"68","author":"W Liu","year":"2008","unstructured":"Liu W, Cheng S, Asa SL, Ezzat S (2008) The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis. Cancer Res 68(19):8104\u20138112","journal-title":"Cancer Res"},{"key":"6531_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108458","volume":"247","author":"F Liu","year":"2023","unstructured":"Liu F, Wu Q, Dong Z, Liu K (2023) Integrins in cancer: emerging mechanisms and therapeutic opportunities. Pharmacol Ther 247:108458","journal-title":"Pharmacol Ther"},{"issue":"1","key":"6531_CR20","first-page":"69","volume":"56","author":"Z Lv","year":"2020","unstructured":"Lv Z, Yang Y, Yang C (2020) Integrin \u03b17 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma. Int J Oncol 56(1):69\u201384","journal-title":"Int J Oncol"},{"issue":"3","key":"6531_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.17849\/insm-47-03-143-158.1","volume":"47","author":"AF Milano","year":"2018","unstructured":"Milano AF (2018) Thyroid cancer: 20-year comparative mortality and survival analysis of six thyroid cancer histologic subtypes by age, sex, race, stage, cohort entry time-period and disease duration (SEER*Stat 8.3.2) a systematic review of 145,457 cases for diagnosis years 1993-2013. J Insur Med 47(3):143\u2013158","journal-title":"J Insur Med"},{"key":"6531_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1749-6632.1991.tb43701.x","volume":"614","author":"DF Mosher","year":"1991","unstructured":"Mosher DF, Fogerty FJ, Chernousov MA, Barry EL (1991) Assembly of fibronectin into extracellular matrix. Ann N Y Acad Sci 614:167\u2013180","journal-title":"Ann N Y Acad Sci"},{"issue":"14","key":"6531_CR23","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.7150\/thno.82492","volume":"13","author":"S Pan","year":"2023","unstructured":"Pan S, Zhu J, Liu P, Wei Q, Zhang S, An W et al (2023) FN1 mRNA 3\u2019-UTR supersedes traditional fibronectin 1 in facilitating the invasion and metastasis of gastric cancer through the FN1 3\u2019-UTR-let-7i-5p-THBS1 axis. Theranostics 13(14):5130\u20135150","journal-title":"Theranostics"},{"issue":"Pt 20","key":"6531_CR24","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1242\/jcs.00059","volume":"115","author":"R Pankov","year":"2002","unstructured":"Pankov R, Yamada KM (2002) Fibronectin at a glance. J Cell Sci 115(Pt 20):3861\u20133863","journal-title":"J Cell Sci"},{"issue":"11","key":"6531_CR25","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74(11):2913\u20132921","journal-title":"Cancer Res"},{"issue":"1","key":"6531_CR26","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13046-021-01908-8","volume":"40","author":"S Spada","year":"2021","unstructured":"Spada S, Tocci A, Di Modugno F, Nistic\u00f2 P (2021) Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology. J Exp Clin Cancer Res 40(1):102","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"6531_CR27","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ajpath.2013.05.010","volume":"183","author":"LZ Tan","year":"2013","unstructured":"Tan LZ, Song Y, Nelson J, Yu YP, Luo JH (2013) Integrin \u03b17 binds tissue inhibitor of metalloproteinase 3 to suppress growth of prostate cancer cells. Am J Pathol 183(3):831\u2013840","journal-title":"Am J Pathol"},{"issue":"9","key":"6531_CR28","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/ijc.29251","volume":"136","author":"C La Vecchia","year":"2015","unstructured":"La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F et al (2015) Thyroid cancer mortality and incidence: a global overview. Int J Cancer 136(9):2187\u20132195","journal-title":"Int J Cancer"},{"issue":"1","key":"6531_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.apsb.2021.07.023","volume":"12","author":"J Wang","year":"2022","unstructured":"Wang J, Hu K, Cai X, Yang B, He Q, Wang J et al (2022) Targeting PI3K\/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm Sin B 12(1):18\u201332","journal-title":"Acta Pharm Sin B"},{"issue":"7","key":"6531_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119785","volume":"1871","author":"J Wang","year":"2024","unstructured":"Wang J, Wang Y, Zhu J, Wang L, Huang Y, Zhang H et al (2024) Promoter hypermethylation-induced downregulation of ITGA7 promotes colorectal cancer proliferation and migration by activating the PI3K\/AKT\/NF-\u03baB pathway. Biochim Biophys Acta Mol Cell Res 1871(7):119785","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"9","key":"6531_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03018-3","volume":"11","author":"T Wu","year":"2020","unstructured":"Wu T, Zhang DL, Wang JM, Jiang JY, Du X, Zeng XY et al (2020) TRIM29 inhibits miR-873-5P biogenesis via CYTOR to upregulate fibronectin 1 and promotes invasion of papillary thyroid cancer cells. Cell Death Dis 11(9):813","journal-title":"Cell Death Dis"},{"issue":"7","key":"6531_CR32","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S0165-6147(03)00163-9","volume":"24","author":"MP Wymann","year":"2003","unstructured":"Wymann MP, Zvelebil M, Laffargue M (2003) Phosphoinositide 3-kinase signalling--which way to target? Trends Pharmacol Sci 24(7):366\u2013376","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"6531_CR33","doi-asserted-by":"publisher","first-page":"11983","DOI":"10.1002\/cam4.5873","volume":"12","author":"X Xu","year":"2023","unstructured":"Xu X, Shen L, Li W, Liu X, Yang P, Cai J (2023) ITGA5 promotes tumor angiogenesis in cervical cancer. Cancer Med 12(10):11983\u201311999","journal-title":"Cancer Med"},{"issue":"1","key":"6531_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0954-x","volume":"18","author":"J Yang","year":"2019","unstructured":"Yang J, Nie J, Ma X, Wei Y, Peng Y, Wei X (2019) Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer 18(1):26","journal-title":"Mol Cancer"},{"issue":"12","key":"6531_CR35","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/s41374-020-0451-2","volume":"100","author":"C Yang","year":"2020","unstructured":"Yang C, Wang C, Zhou J, Liang Q, He F, Li F et al (2020) Fibronectin 1 activates WNT\/\u03b2-catenin signaling to induce osteogenic differentiation via integrin \u03b21 interaction. Lab Invest 100(12):1494\u20131502","journal-title":"Lab Invest"},{"issue":"1","key":"6531_CR36","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13046-019-1290-0","volume":"38","author":"W Zhang","year":"2019","unstructured":"Zhang W, Lu Y, Li X, Zhang J, Lin W, Zhang W et al (2019) IPO5 promotes the proliferation and tumourigenicity of colorectal cancer cells by mediating RASAL2 nuclear transportation. J Exp Clin Cancer Res 38(1):296","journal-title":"J Exp Clin Cancer Res"},{"key":"6531_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15102720","author":"H Zheng","year":"2023","unstructured":"Zheng H, Zhang M, Gao D, Zhang X, Cai H, Cui Z et al (2023) PLA2R1 inhibits differentiated thyroid cancer proliferation and migration via the FN1-mediated ITGB1\/FAK axis. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15102720","journal-title":"Cancers (Basel)"},{"issue":"1","key":"6531_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06441-2","volume":"23","author":"J Zhou","year":"2025","unstructured":"Zhou J, Cheng A, Guo J, Liu Y, Li X, Chen M et al (2025) Targeting PRDX2 to inhibit tumor growth and metastasis in triple-negative breast cancer: the role of FN1 and the PI3K\/AKT\/SP1 pathway. J Transl Med 23(1):434","journal-title":"J Transl Med"},{"issue":"4","key":"6531_CR39","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41419-022-04817-6","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu Y, Peng X, Zhou Q, Tan L, Zhang C, Lin S et al (2022) METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition. Cell Death Dis 13(4):358","journal-title":"Cell Death Dis"},{"issue":"7","key":"6531_CR40","first-page":"479","volume":"10","author":"BL Ziober","year":"1999","unstructured":"Ziober BL, Chen YQ, Ramos DM, Waleh N, Kramer RH (1999) Expression of the alpha7beta1 laminin receptor suppresses melanoma growth and metastatic potential. Cell Growth Differ 10(7):479\u2013490","journal-title":"Cell Growth Differ"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-026-06531-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06531-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-026-06531-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:09:34Z","timestamp":1788134974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-026-06531-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["6531"],"URL":"https:\/\/doi.org\/10.1007\/s00432-026-06531-8","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"21 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of General Hospital of Ningxia Medical University and written informed consent was provided by all patients prior to the study start. All procedures were performed in accordance with the ethical standards of the Institutional Review Board and The Declaration of Helsinki, and its later amendments or comparable ethical standards. All animal experiments were complied with the ARRIVE guidelines and performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The experiments were approved by the Institutional Animal Care and Use Committee of General Hospital of Ningxia Medical University.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"171"}}